BridgeMD
New treatment option for Labor, Induced
Official title Membrane Stripping for Cervical Ripening
ClinicalTrials.gov ID: NCT06591247
What this study is testing
What is PGE2?
PGE2 is an investigational medicine, being studied as a potential treatment for labor, induced.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction. The study population consists of women undergoing labor induction.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only. Healthy volunteers may be eligible.
You may be able to join if
- Patients aged 18 and above
- Patients with a cervical dilation of at least 1 cm
- Full-term pregnancy
- Cephalic presentation
- No contraindication to vaginal delivery
You likely can't join if
- Patients with rupture of membranes
- Patients who do not require cervical ripening and proceed directly to the delivery room for induction with oxytocin
- Patients for whom the use of a double-balloon catheter/PGE2 is contraindicated
- Twin pregnancies
- Pregnancies with macrosomic fetuses where vaginal delivery is contraindicated
- Patients with maternal or fetal pathologies that do not allow for vaginal delivery due to concerns about fetal or maternal distress
The study team makes the final eligibility decision.
Where it's taking place
- Kfar Saba, Central District, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kfar Saba, Central District, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.